Advertisement
Advertisement
U.S. Markets open in 8 hrs 11 mins
Advertisement
Advertisement
Advertisement
Advertisement

Dicerna Pharmaceuticals, Inc. (DRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.220.00 (0.00%)
At close: 04:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/26/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 340.14
52 Week Low 319.06
50-Day Moving Average 331.45
200-Day Moving Average 328.97

Share Statistics

Avg Vol (3 month) 33.03M
Avg Vol (10 day) 32.81M
Shares Outstanding 577.91M
Implied Shares Outstanding 6N/A
Float 860.15M
% Held by Insiders 17.43%
% Held by Institutions 188.54%
Shares Short (Dec 14, 2021) 44.77M
Short Ratio (Dec 14, 2021) 40.84
Short % of Float (Dec 14, 2021) 46.39%
Short % of Shares Outstanding (Dec 14, 2021) 46.12%
Shares Short (prior month Nov 14, 2021) 42.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin -64.53%
Operating Margin (ttm)-62.88%

Management Effectiveness

Return on Assets (ttm)-10.43%
Return on Equity (ttm)-95.22%

Income Statement

Revenue (ttm)192.85M
Revenue Per Share (ttm)2.52
Quarterly Revenue Growth (yoy)28.80%
Gross Profit (ttm)-41.08M
EBITDA -116.73M
Net Income Avi to Common (ttm)-124.44M
Diluted EPS (ttm)-1.63
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)565.51M
Total Cash Per Share (mrq)7.26
Total Debt (mrq)64.42M
Total Debt/Equity (mrq)59.83
Current Ratio (mrq)2.46
Book Value Per Share (mrq)1.38

Cash Flow Statement

Operating Cash Flow (ttm)21.05M
Levered Free Cash Flow (ttm)-45.58M
Advertisement
Advertisement